Literature DB >> 30259273

Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.

Marton Tompa1, Ferenc Kalovits1,2, Adam Nagy3, Bernadette Kalman4,5.   

Abstract

Glioblastoma (GBM), a highly lethal brain tumor, has been comprehensively characterized at the molecular level with the identification of several potential treatment targets. Data concerning the Wnt pathway are relatively sparse, but apparently very important in defining several aspects of tumor biology. The Wnt ligands are involved in numerous basic biological processes including regulation of embryogenic development, cell fate determination, and organogenesis, but growing amount of data also support the roles of Wnt pathways in the formation of many tumors, including gliomas. Two main Wnt pathways are distinguished: the canonical (β-catenin) and non-canonical (planar cell polarity, Wnt/Ca2+) routes. Wnt signaling regulates glioma stem cells (GSCs), thereby defining invasive potential, recurrence, and treatment resistance of GBM. Some observations suggest that the Wnt pathways are differentially active in molecular subtypes of this tumor, thereby may also guide prognostication and novel therapeutic decisions. In this review, we highlight main elements and biological relevance of the Wnt pathways, primarily focusing on the pathogenesis and subtypes of GBM. Finally, we briefly summarize newer therapeutic strategies targeting networks of the Wnt signaling cascades and their molecular associates that appear to be marked contributors to GBM aggressiveness.

Entities:  

Keywords:  Glioblastoma; Glioma stem cells; Molecular subgroups; Treatment targets; Wnt pathways

Mesh:

Substances:

Year:  2018        PMID: 30259273     DOI: 10.1007/s12017-018-8514-x

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  127 in total

Review 1.  Non-canonical Wnt signalling and regulation of gastrulation movements.

Authors:  Masazumi Tada; Miguel L Concha; Carl Philipp Heisenberg
Journal:  Semin Cell Dev Biol       Date:  2002-06       Impact factor: 7.727

2.  Human glioblastoma arises from subventricular zone cells with low-level driver mutations.

Authors:  Joo Ho Lee; Jeong Eun Lee; Jee Ye Kahng; Se Hoon Kim; Jun Sung Park; Seon Jin Yoon; Ji-Yong Um; Woo Kyeong Kim; June-Koo Lee; Junseong Park; Eui Hyun Kim; Ji-Hyun Lee; Joon-Hyuk Lee; Won-Suk Chung; Young Seok Ju; Sung-Hong Park; Jong Hee Chang; Seok-Gu Kang; Jeong Ho Lee
Journal:  Nature       Date:  2018-08-01       Impact factor: 49.962

Review 3.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

4.  ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity.

Authors:  Kailiang Zhang; Shanjun Zhu; Yanwei Liu; Xiaoqun Dong; Zhendong Shi; Anling Zhang; Chaoyong Liu; Luyue Chen; Jianwei Wei; Peiyu Pu; Jianning Zhang; Tao Jiang; Lei Han; Chunsheng Kang
Journal:  Cancer Lett       Date:  2014-11-27       Impact factor: 8.679

5.  Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice.

Authors:  Marie Anson; Anne-Marie Crain-Denoyelle; Véronique Baud; Fanny Chereau; Angélique Gougelet; Benoit Terris; Satoshi Yamagoe; Sabine Colnot; Mireille Viguier; Christine Perret; Jean-Pierre Couty
Journal:  J Clin Invest       Date:  2012-01-17       Impact factor: 14.808

6.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

7.  Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.

Authors:  Jinlong Shi; Baolan Sun; Wei Shi; Hao Zuo; Daming Cui; Lanchun Ni; Jian Chen
Journal:  Tumour Biol       Date:  2014-10-05

8.  miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.

Authors:  Fotini M Kouri; Lisa A Hurley; Weston L Daniel; Emily S Day; Youjia Hua; Liangliang Hao; Chian-Yu Peng; Timothy J Merkel; Markus A Queisser; Carissa Ritner; Hailei Zhang; C David James; Jacob I Sznajder; Lynda Chin; David A Giljohann; John A Kessler; Marcus E Peter; Chad A Mirkin; Alexander H Stegh
Journal:  Genes Dev       Date:  2015-04-01       Impact factor: 11.361

Review 9.  Roles of Wnt Target Genes in the Journey of Cancer Stem Cells.

Authors:  Jee-Heun Kim; So-Yeon Park; Youngsoo Jun; Ji-Young Kim; Jeong-Seok Nam
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

10.  FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.

Authors:  M Asad; M K Wong; T Z Tan; M Choolani; J Low; S Mori; D Virshup; J P Thiery; R Y-J Huang
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

View more
  14 in total

1.  Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.

Authors:  Alisa Förster; Frank Brand; Rouzbeh Banan; Robert Hüneburg; Christine A M Weber; Wiebke Ewert; Jessica Kronenberg; Christopher Previti; Natalie Elyan; Ulrike Beyer; Helge Martens; Bujung Hong; Jan H Bräsen; Andreas Erbersdobler; Joachim K Krauss; Martin Stangel; Amir Samii; Stephan Wolf; Matthias Preller; Stefan Aretz; Bettina Wiese; Christian Hartmann; Ruthild G Weber
Journal:  Acta Neuropathol       Date:  2021-04-30       Impact factor: 17.088

2.  Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers.

Authors:  Jiabin Xu; Alexey Koval; Vladimir L Katanaev
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

Review 3.  A Key Pathway to Cancer Resilience: The Role of Autophagy in Glioblastomas.

Authors:  Elisa Helena Farias Jandrey; Marcelle Bezerra; Lilian Tiemi Inoue; Frank B Furnari; Anamaria Aranha Camargo; Érico Tosoni Costa
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

4.  Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review.

Authors:  Neha Singh; Alexandra Miner; Lauren Hennis; Sandeep Mittal
Journal:  Cancer Drug Resist       Date:  2021-03-19

Review 5.  Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies.

Authors:  Zoltan Kraboth; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2019-08-03       Impact factor: 3.201

6.  The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I.

Authors:  Francesca Bufalieri; Miriam Caimano; Ludovica Lospinoso Severini; Irene Basili; Francesco Paglia; Luigi Sampirisi; Elena Loricchio; Marialaura Petroni; Gianluca Canettieri; Antonio Santoro; Luca D'Angelo; Paola Infante; Lucia Di Marcotullio
Journal:  Cancers (Basel)       Date:  2020-01-30       Impact factor: 6.639

Review 7.  The Implications for Cells of the Lipid Switches Driven by Protein-Membrane Interactions and the Development of Membrane Lipid Therapy.

Authors:  Manuel Torres; Catalina Ana Rosselló; Paula Fernández-García; Victoria Lladó; Or Kakhlon; Pablo Vicente Escribá
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

Review 8.  Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells.

Authors:  Stefano Thellung; Alessandro Corsaro; Alessia G Bosio; Martina Zambito; Federica Barbieri; Michele Mazzanti; Tullio Florio
Journal:  Cells       Date:  2019-11-18       Impact factor: 6.600

Review 9.  Radioresistance in Glioblastoma and the Development of Radiosensitizers.

Authors:  Md Yousuf Ali; Claudia R Oliva; Abu Shadat M Noman; Bryan G Allen; Prabhat C Goswami; Yousef Zakharia; Varun Monga; Douglas R Spitz; John M Buatti; Corinne E Griguer
Journal:  Cancers (Basel)       Date:  2020-09-03       Impact factor: 6.639

Review 10.  Hippo Pathway in Regulating Drug Resistance of Glioblastoma.

Authors:  Giacomo Casati; Laura Giunti; Anna Lisa Iorio; Arianna Marturano; Luisa Galli; Iacopo Sardi
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.